Rise Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $88.7K | Sell |
1,915
-608
| -24% | -$28.1K | 0.04% | 168 |
|
|
2025
Q1 | $154K | Buy |
2,523
+498
| +25% | +$30.4K | 0.07% | 106 |
|
|
2024
Q4 | $115K | Sell |
2,025
-135
| -6% | -$7.64K | 0.06% | 133 |
|
|
2024
Q3 | $112K | Sell |
2,160
-106
| -5% | -$5.49K | 0.05% | 141 |
|
|
2024
Q2 | $94.1K | Buy |
2,266
+341
| +18% | +$14.2K | 0.05% | 154 |
|
|
2024
Q1 | $104K | Buy |
1,925
+1,293
| +205% | +$70.1K | 0.06% | 149 |
|
|
2023
Q4 | $32.4K | Buy |
632
+7
| +1% | +$359 | 0.02% | 209 |
|
|
2023
Q3 | $36.3K | Sell |
625
-3
| -0.5% | -$174 | 0.03% | 168 |
|
|
2023
Q2 | $40.2K | Sell |
628
-383
| -38% | -$24.5K | 0.03% | 167 |
|
|
2023
Q1 | $70.1K | Sell |
1,011
-10
| -1% | -$693 | 0.05% | 130 |
|
|
2022
Q4 | $73.4K | Buy |
1,021
+7
| +0.7% | +$503 | 0.06% | 123 |
|
|
2022
Q3 | $72K | Buy |
1,014
+7
| +0.7% | +$497 | 0.06% | 119 |
|
|
2022
Q2 | $78K | Buy |
1,007
+139
| +16% | +$10.8K | 0.08% | 107 |
|
|
2022
Q1 | $63K | Sell |
868
-34
| -4% | -$2.47K | 0.06% | 126 |
|
|
2021
Q4 | $56.2K | Buy |
+902
| New | +$56.2K | 0.05% | 137 |
|